5月6日富国精准医疗混合A净值下跌1.04%，近1个月累计上涨3.36%

Core Viewpoint - The report highlights the performance and holdings of the Fuqua Precision Medical Mixed A Fund, indicating its recent decline in net value but strong returns over various time frames [1]. Fund Performance - The latest net value of Fuqua Precision Medical Mixed A is 2.8205 yuan, reflecting a decrease of 1.04% - The fund's return over the past month is 3.36%, ranking 131 out of 1587 in its category - Over the last three months, the fund has achieved a return of 28.71%, ranking 6 out of 1582 - Year-to-date, the fund has returned 26.58%, ranking 17 out of 1574 [1]. Fund Holdings - The top ten stock holdings of Fuqua Precision Medical Mixed A account for a total of 69.71%, with the following allocations: - Baile Tianheng: 9.66% - Haizike: 9.65% - Kelun Pharmaceutical: 9.10% - Huitai Medical: 9.05% - Zai Jian Pharmaceutical-U: 7.84% - Heng Rui Pharmaceutical: 5.95% - Nuo Cheng Jian Hua-U: 5.29% - Xin Nuo Wei: 5.11% - Bai Ji Shen Zhou-U: 4.91% - Zuo Li Pharmaceutical: 3.15% [1]. Fund Manager Background - Zhao Wei, the fund manager, has a master's degree and has held various positions in pharmaceutical research and investment management, including roles at GlaxoSmithKline and several fund management companies - He has been with Fuqua Fund Management since March 2021 and has managed multiple funds prior to his current role [2].